Nanjing, China

Miao Wei

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: L&p Food Ingredient Co., Ltd, Langnai Biotech Co., Ltd. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miao Wei. Retrieved from https://idiyas.com/inventor/miao-wei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miao Wei: Innovator in Biotech

Introduction

Miao Wei is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly through his innovative work on enzymes.

Latest Patents

Miao Wei holds a patent for a 3-epimerase and the polynucleotide encoding the same. This invention includes a 3-epimerase, an encoding polynucleotide, a nucleic acid construct, a vector, and a host cell that comprises the polynucleotide. Additionally, he has developed a method for producing the 3-epimerase and outlined its various uses.

Career Highlights

Throughout his career, Miao Wei has worked with several companies, including Langnai Biotech Co., Ltd and L&P Food Ingredient Co., Ltd. His expertise in biotechnology has allowed him to contribute to advancements in the industry.

Collaborations

Miao Wei has collaborated with notable colleagues such as Sanyong Wang and Chunrong Li. Their combined efforts have furthered research and development in their respective fields.

Conclusion

Miao Wei's contributions to biotechnology, particularly through his patent on 3-epimerase, highlight his role as an innovator in the industry. His work continues to influence advancements in enzyme technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…